Provided By GlobeNewswire
Last update: Aug 10, 2023
Successful End-of-Phase 2 meeting with FDA regarding AL102 for the treatment of desmoid tumors
Enrollment in the Phase 3 segment of RINGSIDE trial evaluating AL102 continuing globally as planned
Read more at globenewswire.com